-
1
-
-
67349281375
-
Screening caused rising incidence rates of ductal carcinoma in situ of the breast
-
van Steenbergen L.N., Voogd A.C., Roukema J.A., Louwman W.J., Duijm L.E., Coebergh J.W., et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2008, 115(1):181-183.
-
(2008)
Breast Cancer Res Treat
, vol.115
, Issue.1
, pp. 181-183
-
-
van Steenbergen, L.N.1
Voogd, A.C.2
Roukema, J.A.3
Louwman, W.J.4
Duijm, L.E.5
Coebergh, J.W.6
-
2
-
-
84882940079
-
Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases
-
Cutuli B., Lemanski C., Le Blanc-Onfroy M., de Lafontan B., Cohen-Solal-Le-Nir C., Fondrinier E., et al. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases. Cancer/Radiother 2013, 17(3):196-201.
-
(2013)
Cancer/Radiother
, vol.17
, Issue.3
, pp. 196-201
-
-
Cutuli, B.1
Lemanski, C.2
Le Blanc-Onfroy, M.3
de Lafontan, B.4
Cohen-Solal-Le-Nir, C.5
Fondrinier, E.6
-
3
-
-
84891512298
-
Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcomes after a recurrence, from EORTC 10853 randomized phase III trial
-
Donker M., Litiere S., Werutsky G., Julien J.P., Fentiman I.S., Agresti R., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcomes after a recurrence, from EORTC 10853 randomized phase III trial. JClin Oncol 2013, 31(32):4054-4059.
-
(2013)
JClin Oncol
, vol.31
, Issue.32
, pp. 4054-4059
-
-
Donker, M.1
Litiere, S.2
Werutsky, G.3
Julien, J.P.4
Fentiman, I.S.5
Agresti, R.6
-
4
-
-
33746408229
-
Comprehensive side-effect profile of anastrozole and Tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial
-
Buzdar A., Howell A., Cuzick J., Wale C., Distler W., Hoctin-Boes G., et al. Comprehensive side-effect profile of anastrozole and Tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 2006, 7:633-643.
-
(2006)
Lancet Oncol
, vol.7
, pp. 633-643
-
-
Buzdar, A.1
Howell, A.2
Cuzick, J.3
Wale, C.4
Distler, W.5
Hoctin-Boes, G.6
-
5
-
-
29544433211
-
Acomparison of letrozole and Tamoxifen in postmenopausal women with early breast cancer
-
Acomparison of letrozole and Tamoxifen in postmenopausal women with early breast cancer. NEngl J Med 2005, 353:2747-2753. The Breast International Group 1-98 Collaborative Group.
-
(2005)
NEngl J Med
, vol.353
, pp. 2747-2753
-
-
-
6
-
-
0036230556
-
The molecular perspective: Tamoxifen and the estrogen receptor
-
Goodsell D.S. The molecular perspective: Tamoxifen and the estrogen receptor. Oncologist 2002, 7:163-164.
-
(2002)
Oncologist
, vol.7
, pp. 163-164
-
-
Goodsell, D.S.1
-
7
-
-
34548144485
-
Tamoxifen for early breast cancer
-
Tamoxifen for early breast cancer. Cochrane Database Syst Rev 2001, (1). Early Breast Cancer Trialists' Collaborative Group.
-
(2001)
Cochrane Database Syst Rev
, Issue.1
-
-
-
8
-
-
0345099342
-
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy
-
Kerlikowske K., Molinaro A., Cha I., Ljung B.M., Ernster V.L., Stewart K., et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. JNatl Cancer Inst 2003, 95:1692-1702.
-
(2003)
JNatl Cancer Inst
, vol.95
, pp. 1692-1702
-
-
Kerlikowske, K.1
Molinaro, A.2
Cha, I.3
Ljung, B.M.4
Ernster, V.L.5
Stewart, K.6
-
9
-
-
0029121769
-
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
-
Page D.L., Dupont W.D., Rogers L.W., Jensen R.A., Schuyler P.A. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995, 76:1197-2000.
-
(1995)
Cancer
, vol.76
, pp. 1197-2000
-
-
Page, D.L.1
Dupont, W.D.2
Rogers, L.W.3
Jensen, R.A.4
Schuyler, P.A.5
-
10
-
-
0035108950
-
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
-
Bijker N., Peterse J.L., Duchateau L., Robanus-Maandag E.C., Bosch C.A., Duval C., et al. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2001, 84:539-544.
-
(2001)
Br J Cancer
, vol.84
, pp. 539-544
-
-
Bijker, N.1
Peterse, J.L.2
Duchateau, L.3
Robanus-Maandag, E.C.4
Bosch, C.A.5
Duval, C.6
-
12
-
-
84870403853
-
Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]
-
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. http://www.cochrane-handbook.org.
-
The Cochrane Collaboration
-
-
Higgins, J.P.T.1
Green, S.2
-
13
-
-
79952845819
-
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
-
Wapnir I.L., Dignam J.J., Fisher B., Mamounas E.P., Anderson S.J., Julian T.B., et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. JNatl Cancer Inst 2011, 103(6):478-488.
-
(2011)
JNatl Cancer Inst
, vol.103
, Issue.6
, pp. 478-488
-
-
Wapnir, I.L.1
Dignam, J.J.2
Fisher, B.3
Mamounas, E.P.4
Anderson, S.J.5
Julian, T.B.6
-
14
-
-
78650700810
-
Effect of Tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
-
Cuzick I., Sestak S., Pinder I.O., Ellis S., Forsyth N.J., Bundred, et al. Effect of Tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011, 12:21-29.
-
(2011)
Lancet Oncol
, vol.12
, pp. 21-29
-
-
Cuzick, I.1
Sestak, S.2
Pinder, I.O.3
Ellis, S.4
Forsyth, N.J.5
Bundred6
-
15
-
-
80052297510
-
Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials
-
Petrelli F., Barni S. Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials. Radiother Oncol 2011, 100(2):195-199.
-
(2011)
Radiother Oncol
, vol.100
, Issue.2
, pp. 195-199
-
-
Petrelli, F.1
Barni, S.2
|